AIM ImmunoTech AIM Insider Ownership

NYSE AIM

$0.17 +0.00 (+2.94%)

As of: Oct 20, 2026 · 3:57 PM EDT

Insider Holdings by Owner

254.92K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

0.701%

▲+0.248% pp QoQ

Shares Held by Insiders

194.44K

filed for Sep 2026

▲+47.82% QoQ

Shares Outstanding

27.72Mn

27,724,245 shares

Direct Holdings

191.00K

Indirect: 3.44K

Net Shares Traded (QoQ)

+62.90K

net buying in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the trailing 12 months, AIM insiders bought $13,456 worth of shares (62.9K shares) in open-market trades, with no open-market sales.

Among AIM insiders, Thomas K. Equels (CEO & President) bought the most stock on the open market in the past 12 months: $13,456 (62.9K shares), most recently on September 17, 2026.
In transactions other than open-market trades, AIM ImmunoTech insiders received 2.8K shares in stock awards and acquired 25K shares through option exercises and conversions over the past 12 months.
Per Business Quant, AIM insiders together hold 194.44K shares based on their latest Form 4 filings, or 0.70% of the 27.72Mn shares outstanding; that total is up 47.82% from 131.54K shares at the end of Q2 2026 and up 158.35% from 75.26K shares at the end of Q3 2025.
Of the 194.44K shares held by AIM ImmunoTech insiders, 191K shares (98.23%) are held directly and 3.44K shares (1.77%) indirectly, through trusts, partnerships, family members and other entities.
Business Quant counts 7 insiders with holdings in AIM ImmunoTech stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
AIM ImmunoTech's top three insider holders by shares held are Thomas K. Equels (CEO & President, 126.82K shares), David I. Chemerow (Director, 31.88K shares) and Ted D. Kellner (Director, 19.7K shares).
The holding of Thomas K. Equels makes up 65.22% of all shares held by AIM ImmunoTech insiders.
A total of 9 Form 4 filings with transactions in AIM ImmunoTech stock were made over the past 12 months, by 2 insiders.
These insider figures for AIM ImmunoTech are based on Form 4 filings through September 18, 2026.

Form 4 Holdings

Insiders Holding AIM

Insiders 7

Shares held 254.92K

Of outstanding 0.919%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Thomas K Equels	Ceo President	190,744	190,744	74.8%	18 Sep, 2026
2	David I. Chemerow	Director	28,441	28,441	11.2%	16 Mar, 2026
3	Ted D Kellner	Director	19,695	19,695	7.7%	23 Apr, 2025
4	William M Mitchell	Director	5,217	5,217	2.0%	23 Apr, 2025
5	Peter W Iii Rodino	Coo, Secretary, Gen. Counsel	4,018	4,018	1.6%	04 Apr, 2025
6	Stewart Appelrouth	Director	3,887	3,887	1.5%	03 Jan, 2025
7	Nancy Bryan	Director	2,919	2,919	1.1%	18 Mar, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

594 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
17 Sep, 2026	Thomas K Equels	Ceo President	Acquired P	24,000	$0.21	$4.99K	126,822	Direct
16 Sep, 2026	Thomas K Equels	Ceo President	Acquired P	11,000	$0.21	$2.31K	102,822	Direct
15 Sep, 2026	Thomas K Equels	Ceo President	Acquired P	22,000	$0.22	$4.86K	91,822	Direct
14 Sep, 2026	Thomas K Equels	Ceo President	Acquired P	5,900	$0.22	$1.29K	69,822	Direct
12 Mar, 2026	David I. Chemerow	Director	Acquired C	25,000	$0.00	$0	28,441	Direct
12 Mar, 2026	Thomas K Equels	Ceo President	Acquired C	25,000	$0.00	$0	63,922	Direct
12 Mar, 2026	David I. Chemerow	Director	Disposed C	25	$0.00	$0	0	Direct
12 Mar, 2026	Thomas K Equels	Ceo President	Disposed C	25	$0.00	$0	0	Direct
06 Mar, 2026	David I. Chemerow	Director	Acquired J	25	$25,000.00	$625.00K	25	Direct
06 Mar, 2026	Thomas K Equels	Ceo President	Acquired J	25	$25,000.00	$625.00K	25	Direct
06 Mar, 2026	David I. Chemerow	Director	Acquired J	50,000	$0.00	$0	50,000	Direct
06 Mar, 2026	Thomas K Equels	Ceo President	Acquired J	50,000	$0.00	$0	50,000	Direct
05 Feb, 2026	David I. Chemerow	Director	Acquired A	2,800	$1.23	$3.44K	3,441	Indirect
13 Jun, 2025	Thomas K Equels	Ceo President	Acquired P	107	$7.70	$824	38,885	Direct
12 Jun, 2025	Thomas K Equels	Ceo President	Acquired P	103	$8.70	$896	38,675	Direct
11 Apr, 2025	Thomas K Equels	Ceo President	Acquired P	1,968,504	$2.54	$5.00Mn	38,675	Direct
11 Apr, 2025	Ted D Kellner	Director	Acquired P	1,968,504	$2.54	$5.00Mn	19,695	Direct
11 Apr, 2025	William M Mitchell	Director	Acquired P	196,851	$2.54	$500.00K	5,217	Direct
04 Apr, 2025	Thomas K Equels	Ceo President	Acquired P	41,000	$6.30	$258.30K	18,990	Direct
04 Apr, 2025	Peter W Iii Rodino	Coo, Secretary, Gen. Counsel	Acquired P	500	$8.70	$4.35K	4,018	Direct

Showing 1 to 20 of 594 transactions